Michelle A. Krayer

FDA investigator

Appears on 11 documents from 2019 to 2024, mostly at sites in Texas. Most often cites responsibilities of quality control unit (21 CFR 211.22).

11
Documents on file
4.7
Observations per 483
2019
First seen
2024
Most recent

What they cite most

From 52 observations

Activity by year

2019: 2, 2020: 1, 2021: 2, 2022: 2, 2023: 3, 2024: 1

Where

Texas 10 · Oklahoma 1

Is Michelle A. Krayer coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Qualgen, LLCMar 19, 2024 · Edmond, Oklahoma
483 ARG Laboratories, IncSep 20, 2023 · Dallas, Texas
483 Fruit of the Earth, Inc.Mar 31, 2023 · Grand Prairie, Texas
483 TAKA USA, INC. dba Cosmetic InnovationsFeb 7, 2023 · Coppell, Texas
483 Mission Pharmacal CompanySep 22, 2022 · Boerne, Texas
483 Dhaliwal Pharmaceuticals Laboratories, LLCMar 1, 2022 · MESQUITE, Texas
483 Taka USA Inc. dba Cosmetic InnovationsSep 27, 2021 · Coppell, Texas

About this profile

What does Michelle A. Krayer inspect?

Michelle A. Krayer appears on 11 documents on file covering 8 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.192 and 21 CFR 211.165(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michelle A. Krayer is dated Mar 19, 2024.